Podcast TCTMD Talking Points

A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI

C. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.

Listen to previous episodes | Download via iTunes

TCTMD Talking Points

TCTMD Talking Points

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.